Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Operating Cash Flow
Cash generated by the company's core business operations during the period.
Stereotaxis, Inc.AMEX: STXS
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow grows in line with its trailing trend
Q1 FY2026 operating cash flow of $3.44M (cash outflow) rose 93.5% year over year, in line with the +93.5% change in trailing-twelve-month operating cash flow. Sequentially, it fell 13.3% from the prior quarter. Over 3 fiscal years it compounded at +17.6% a year.
Context
- Operating cash flow amounted to 42.3% of revenue in FY2025, up 10.7 pp from a year earlier.
- Operating cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +93.5% toward the trailing-twelve-month pace of +93.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (13.69M) USD
- Year-over-year change
- -61.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (13.69M) | -61.1% |
| FY2024 | 2024-12-31 | (8.5M) | +7.0% |
| FY2023 | 2023-12-31 | (9.14M) | -8.6% |
| FY2022 | 2022-12-31 | (8.42M) | -185.6% |
| FY2021 | 2021-12-31 | (2.95M) | — |
Operating Cash Flow vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's LTM Mar 2026 operating cash flow of $15.35M is the 2nd largest of the 5 companies compared; the peer median is $14.99M.
- Its year-over-year change of +93.5% is the 2nd highest of 5, against a peer median of +39.0%.
- Operating cash flow amounts to 49.2% of revenue for STXS, versus a peer median of 46.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $25.72M | +128.0% | +14.0% | 63.3% | |
| LTM Mar 2026 | $15.35M | +93.5% | +17.6% | 49.2% | |
| LTM Mar 2026 | $15.23M | +64.0% | +4.1% | 14500.0% | |
| LTM Mar 2026 | $14.75M | +14.0% | +45.7% | 30.4% | |
| LTM Mar 2026 | $9.42M | -47.4% | -33.2% | 9.5% | |
| Peer median (excluding STXS) | $14.99M | +39.0% | +9.1% | 46.9% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Depreciation & Amortization | 106K | 429K | 595K | 969K | 1.56M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.36M | 10.58M | 10.62M | 10.26M | 9.85M |
| Change in Working Capital | 135K | (1.1M) | 612K | 2.51M | (5.62M) |
| Accounts Receivables | (1.89M) | 316K | 1.27M | 691K | (2.02M) |
| Inventory | (1.14M) | (2.91M) | (550K) | 677K | (1.24M) |
| Accounts Payables | 1.43M | (169K) | 218K | 758K | (880K) |
| Other Working Capital | 1.73M | 1.66M | (324K) | 379K | (1.48M) |
| Other Non-Cash Items | (1.83M) | (25K) | (256K) | 1.81M | 2.17M |
| Operating Cash Flow | (2.95M) | (8.42M) | (9.14M) | (8.5M) | (13.69M) |
| Capital Expenditures | (1.4M) | (2.38M) | (366K) | (34K) | (93K) |
| Acquisitions (Net) | 0 | 0 | 0 | 108K | 0 |
| Purchases of Investments | 0 | (19.72M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 20.13M | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.4M) | (22.09M) | 19.77M | 74K | (93K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 547K | 220K | 81K | 297K | 14.76M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 547K | 220K | 81K | 297K | 14.76M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (3.8M) | (30.29M) | 10.71M | (8.13M) | 985K |
| Free Cash Flow | (4.34M) | (10.79M) | (9.51M) | (8.53M) | (13.78M) |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.